SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-442178
Filing Date
2013-11-14
Accepted
2013-11-14 16:23:29
Documents
11
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d605474d10q.htm 10-Q 356515
2 EX-31.1 d605474dex311.htm EX-31.1 6077
3 EX-31.2 d605474dex312.htm EX-31.2 6271
4 EX-32.1 d605474dex321.htm EX-32.1 3252
5 EX-32.2 d605474dex322.htm EX-32.2 3478
  Complete submission text file 0001193125-13-442178.txt   3604662

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cnat-20130930.xml EX-101.INS 487482
7 XBRL TAXONOMY EXTENSION SCHEMA cnat-20130930.xsd EX-101.SCH 32849
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cnat-20130930_cal.xml EX-101.CAL 45847
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cnat-20130930_def.xml EX-101.DEF 126921
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cnat-20130930_lab.xml EX-101.LAB 294675
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cnat-20130930_pre.xml EX-101.PRE 218147
Mailing Address 4365 EXECUTIVE DRIVE Suite 200 San Diego CA 92121
Business Address 4365 EXECUTIVE DRIVE Suite 200 San Diego CA 92121 (858) 558-8130
Conatus Pharmaceuticals Inc (Filer) CIK: 0001383701 (see all company filings)

IRS No.: 203183915 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36003 | Film No.: 131220453
SIC: 2834 Pharmaceutical Preparations